Skip to content

Medical Innovation Meets Regulatory Excellence

Strengthened UK PMS Requirements Coming: Are You Ready?

April 2, 2025 – Do you have medical devices on the market in the UK ? If so, take note: new, strengthened Post-Market Surveillance (PMS) requirements are coming into force in June 2025. The Medical Devices (Post-market Surveillance Requirements) (Amendment) (Great Britain) Regulations 2024 introduce several important updates. While these regulations closely align with the

What do U.S. tariffs mean for Canadian medical device companies?

Updated April 8, 2025 – The U.S. tariffs imposed on goods from Canada presents significant challenges for medical device companies. Despite lobbying by industry associations on both sides of the border, medical devices — including raw materials and parts — are not exempt. In response, Canada has implemented retaliatory tariffs on a wide range of

Navigating MDEL Modernization: What You Need to Know

January 27, 2025 – It’s MDEL Annual Licence Review (ALR) season and, for Medical Device Establishment Licence (MDEL) holders, Health Canada’s ongoing modernization of the MDEL framework brings changes that may affect your regulatory compliance status. Understanding these changes is crucial for ensuring your organization remains compliant with the latest regulatory amendments. Health Canada is

Hospital technologist using digital system

Integrating Real-World Evidence (RWE) into your Medical Device Commercialization Strategy

October 3, 2024 – Medical device regulators around the world have been emphasizing the uses of Real-World Evidence (RWE) to support safety and effectiveness.  Real-world evidence can improve your device’s safety and effectiveness, be leveraged for future regulatory submissions, and can be used to improve your market positioning, clinical claims, and payer acceptance. If you

FDA Releases Updated Cybersecurity Guidance for Medical Devices

March 15, 2024 – On March 13, 2024 the FDA released “Select Updates for the Premarket Cybersecurity Guidance: Section 524B of the FD&C Act”, which includes clarification on several areas in the September 27, 2023 draft guidance document “Cybersecurity in Medical Devices: Quality System Consideration and Content of Premarket Submission.” In addition, recommendations for cybersecurity

5 Items